Astrazeneca Share News (AZN)

LONDON MARKET PRE-OPEN: Strong Reckitt guidance; NatWest backs outlook

(Alliance News) - Stock prices in London are seen opening higher on Friday, making a confident end to a tricky month for markets, which have faced Covid-19 worries in China, alongside rampant inflation and central bank monetary tightening in response.

AstraZeneca wins US approval for generalised myasthenia gravis drug

(Alliance News) - AstraZeneca PLC on Thursday said its drug Ultomiris has been approved by the US Food & Drug Administration for the treatment of adults with generalised myasthenia gravis.

Astrazeneca's Ultomiris receives FDA approval

(Sharecast News) - Drugmaker AstraZeneca's Ultomiris asset has been approved in the US for adults with generalised myasthenia gravis.

AstraZeneca, Daiichi Sankyo cancer drug secures US regulatory boost

(Alliance News) - AstraZeneca PLC on Wednesday said a cancer drug it has helped develop to treat a form of breast cancer has been granted breakthrough therapy designation in the US.

AstraZeneca's Enhertu granted FDA breakthrough therapy designation

(Sharecast News) - Drugmaker AstraZeneca's Enhertu candidate has been granted breakthrough therapy designation in the US for adult patients with HER2-low metastatic breast cancer.

FTSE 100 snaps 3-day losing streak; AB Foods slumps on earnings update

April 26 (Reuters) - London's FTSE 100 inched higher on Tuesday after a three-day sell off, as resource and defensive stocks rose, while HSBC Holdings and Associated British Foods slid following earnings updates.

AstraZeneca's Tremelimumab-Imfinzi combo to get US priority review

(Alliance News) - AstraZeneca PLC on Monday announced its candidate for unresectable liver cancer Tremelimumab has been accepted under priority review by the US Food & Drug Administration.

LONDON MARKET PRE-OPEN: British Land sells Paddington Central stake

(Alliance News) - Stock prices in Europe are seen opening lower on Monday, with a grim Covid-19 situation in China adding to a mountain of worries for equities investors, which included hawkish comments made by Federal Reserve Chair Jerome Powell late last week.

FDA accepts priority review application for AstraZeneca's tremelimumab

(Sharecast News) - Drugmaker AstraZeneca said on Monday that an application for priority review of its tremelimumab asset had been accepted by the US Food and Drug Administration.

UK earnings, trading statements calendar - next 7 days

UK shareholder meetings calendar - next 7 days

AstraZeneca says no severe virus cases or deaths after taking antibody

(Alliance News) - AstraZeneca PLC late Wednesday said a clinical trial found its Evusheld antibody therapy markedly reduced the risk of developing symptomatic Covid-19.

Oxford BioMedica shares fall as warns on 2022 amid Covid jab pause

(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause.

LONDON BROKER RATINGS: Prudential and CRH get upgrades, ITV cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Thursday last week:

AstraZeneca's Enhertu wins priority review by FDA for lung cancer

(Alliance News) - AstraZeneca PLC on Tuesday said its lung cancer antibody drug conjugate Enhertu has received priority review from the Food & Drug Administration in the US.